Source: European neuropsychopharmacology. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, APTIDÃO COGNITIVA, LÍTIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNKHOLM, Klaus e GATTAZ, Wagner Farid. Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder. European neuropsychopharmacology, v. 28, n. 3, p. 361-368, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2018.01.008. Acesso em: 10 out. 2024.APA
Munkholm, K., & Gattaz, W. F. (2018). Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder. European neuropsychopharmacology, 28( 3), 361-368. doi:10.1016/j.euroneuro.2018.01.008NLM
Munkholm K, Gattaz WF. Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder [Internet]. European neuropsychopharmacology. 2018 ; 28( 3): 361-368.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.euroneuro.2018.01.008Vancouver
Munkholm K, Gattaz WF. Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder [Internet]. European neuropsychopharmacology. 2018 ; 28( 3): 361-368.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.euroneuro.2018.01.008